Saleem Abubacker1,2, Dragana Ponjevic2,3, Hyun O Ham4, Phillip B Messersmith4,5, John R Matyas2,3, Tannin A Schmidt1,2,6. 1. a Biomedical Engineering Graduate Program, University of Calgary , Calgary , AB , Canada. 2. b McCaig Institute of Bone and Joint Health , University of Calgary , Calgary , AB , Canada. 3. c Department of Comparative Biology and Experimental Medicine, Faculty of Veterinary Medicine , University of Calgary , Calgary , AB , Canada. 4. d Biomedical Engineering Department , Northwestern University , Evanston , IL , USA. 5. e Departments of Bioengineering and Materials Science and Engineering Department , University of California , Berkeley , CA , USA. 6. f Faculty of Kinesiology , University of Calgary , Calgary , AB , Canada.
Abstract
PURPOSE: The objectives of this study were to assess the cartilage boundary lubricating ability of (1) nonreduced (NR) disulfide-bonded proteoglycan 4 (PRG4) multimers versus PRG4 monomers and (2) NR versus reduced and alkylated (R/A) PRG4 monomers and to assess (3) the ability of NR PRG4 multimers versus monomers to adsorb to an articular cartilage surface. MATERIALS AND METHODS: PRG4 was separated into two preparations, PRG4 multimer enriched (PRG4Multi+) and PRG4 multimer deficient (PRG4Multi-), using size exclusion chromatography (SEC) and characterized by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). The cartilage boundary lubricating ability of PRG4Multi+ and PRG4Multi- was compared at a physiological concentration (450 μg/mL) and assessed over a range of concentrations (45, 150, and 450 μg/mL). R/A and NR PRG4Multi- were evaluated at 450 μg/mL. Immunohistochemistry with anti-PRG4 antibody 4D6 was performed to visualize the adsorption of PRG4 preparations to the surface of articular cartilage explants. RESULTS: Separation into enriched populations of PRG4Multi+ and PRG4Multi- was achieved using SEC and was confirmed by SDS-PAGE. PRG4Multi+ and PRG4Multi- both functioned as effective friction-reducing cartilage boundary lubricants at 450 μg/mL, with PRG4Multi+ being more effective than PRG4Multi-. PRG4Multi+ lubricated in a dose-dependent manner, however, PRG4Multi- did not. R/A PRG4Multi- lubricated similar to NR PRG4Multi-. PRG4-containing solutions showed 4D6 immunoreactivity at the articular surface; the immunoreactive intensity of PRG4Multi+ appeared to be similar to SF, whereas PRG4Multi- appeared to have less intensity. CONCLUSIONS: These results demonstrate that the intermolecular disulfide-bonded multimeric structure of PRG4 is important for its ability to adsorb to a cartilage surface and function as a boundary lubricant. These findings contribute to a greater understanding of the molecular basis of cartilage boundary lubrication of PRG4. Elucidating the PRG4 structure-lubrication function relationship will further contribute to the understanding of PRG4's role in diarthrodial joint homeostasis and disease.
PURPOSE: The objectives of this study were to assess the cartilage boundary lubricating ability of (1) nonreduced (NR) disulfide-bonded proteoglycan 4 (PRG4) multimers versus PRG4 monomers and (2) NR versus reduced and alkylated (R/A) PRG4 monomers and to assess (3) the ability of NR PRG4 multimers versus monomers to adsorb to an articular cartilage surface. MATERIALS AND METHODS:PRG4 was separated into two preparations, PRG4 multimer enriched (PRG4Multi+) and PRG4 multimer deficient (PRG4Multi-), using size exclusion chromatography (SEC) and characterized by sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE). The cartilage boundary lubricating ability of PRG4Multi+ and PRG4Multi- was compared at a physiological concentration (450 μg/mL) and assessed over a range of concentrations (45, 150, and 450 μg/mL). R/A and NR PRG4Multi- were evaluated at 450 μg/mL. Immunohistochemistry with anti-PRG4 antibody 4D6 was performed to visualize the adsorption of PRG4 preparations to the surface of articular cartilage explants. RESULTS: Separation into enriched populations of PRG4Multi+ and PRG4Multi- was achieved using SEC and was confirmed by SDS-PAGE. PRG4Multi+ and PRG4Multi- both functioned as effective friction-reducing cartilage boundary lubricants at 450 μg/mL, with PRG4Multi+ being more effective than PRG4Multi-. PRG4Multi+ lubricated in a dose-dependent manner, however, PRG4Multi- did not. R/A PRG4Multi- lubricated similar to NR PRG4Multi-. PRG4-containing solutions showed 4D6 immunoreactivity at the articular surface; the immunoreactive intensity of PRG4Multi+ appeared to be similar to SF, whereas PRG4Multi- appeared to have less intensity. CONCLUSIONS: These results demonstrate that the intermolecular disulfide-bonded multimeric structure of PRG4 is important for its ability to adsorb to a cartilage surface and function as a boundary lubricant. These findings contribute to a greater understanding of the molecular basis of cartilage boundary lubrication of PRG4. Elucidating the PRG4 structure-lubrication function relationship will further contribute to the understanding of PRG4's role in diarthrodial joint homeostasis and disease.
Authors: J Marcelino; J D Carpten; W M Suwairi; O M Gutierrez; S Schwartz; C Robbins; R Sood; I Makalowska; A Baxevanis; B Johnstone; R M Laxer; L Zemel; C A Kim; J K Herd; J Ihle; C Williams; M Johnson; V Raman; L G Alonso; D Brunoni; A Gerstein; N Papadopoulos; S A Bahabri; J M Trent; M L Warman Journal: Nat Genet Date: 1999-11 Impact factor: 38.330
Authors: Jennifer M Antonacci; Tannin A Schmidt; Lisa A Serventi; Matthew Z Cai; YuYu L Shu; Barbara L Schumacher; C Wayne McIlwraith; Robert L Sah Journal: Arthritis Rheum Date: 2012-09
Authors: J J Kwiecinski; S G Dorosz; T E Ludwig; S Abubacker; M K Cowman; T A Schmidt Journal: Osteoarthritis Cartilage Date: 2011-08-16 Impact factor: 6.576
Authors: Amy C Madl; Chunzi Liu; Daniel Cirera-Salinas; Gerald G Fuller; David Myung Journal: ACS Appl Mater Interfaces Date: 2022-04-13 Impact factor: 10.383
Authors: Nabangshu Das; Nikhil G Menon; Luiz G N de Almeida; Paige S Woods; Miriam L Heynen; Gregory D Jay; Barbara Caffery; Lyndon Jones; Roman Krawetz; Tannin A Schmidt; Antoine Dufour Journal: Front Pharmacol Date: 2021-12-07 Impact factor: 5.810